Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats-Reference-Cited by-同舟云学术

Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats

Published:2021-11 Issue: Volume:910 Page:174451
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Takagi Hiroyuki^ORCID,Ikehara Tatsuya,Hashimoto Kumi,Tanimoto Keiichi,Shimazaki Atsuyuki,Kashiwagi Yuto,Sakamoto Shingo,Yukioka Hideo

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. The subcellular localization of acetyl-CoA carboxylase 2;Abu-Elheiga;Proc. Natl. Acad. Sci. U. S. A.,2000

2. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans;Adams;Diabetes,2004

3. Lipid in skeletal muscle myotubes is associated to the donors' insulin sensitivity and physical activity phenotypes;Bajpeyi;Obesity,2014

4. Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans;Bergman;Diabetologia,2012

5. Regulation of acetyl-CoA carboxylase;Brownsey;Biochem. Soc. Trans.,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy;Metabolism;2024-09

2. Enhanced interactions among gut mycobiomes with the deterioration of glycemic control;Med;2024-08

3. Extracellular vesicles may provide an alternative detoxification pathway during skeletal muscle myoblast ageing;Journal of Extracellular Biology;2024-08

4. Pharmacologic inhibition of lipogenesis for the treatment of NAFLD;Journal of Hepatology;2024-02

5. MITOCHONDRIAL FATTY ACID BETA-OXIDATION: A POSSIBLE THERAPEUTIC TARGET FOR SKELETAL MUSCLE LIPOTOXICITY IN PERIPHERAL ARTERY DISEASE MYOPATHY;EXCLI J;2024